Minneapolis VAMC (111-0)
Minneapolis, Minnesota, 55417, United States
NCT Number: NCT00301626
Background. The ROSCAP Study was a randomized controlled trial in heart disease patients to test the effect of a smoking reduction intervention on cigarettes per day (cpd) and biochemical and clinical indicators of tobacco exposure. .
Looking for future studies?
Notify Me18 year–80 year
All sexes
Interventional
Not applicable
Minneapolis, Minnesota, 55417, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
National Institutes of Health (NIH)
Nih
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03083353
Behavior, Chemically-Induced Disorders
Austin, Texas, United States
View Trial DetailsNCT03194958
Behavior, Behavior, Addictive
St Louis, Missouri, United States
View Trial DetailsNCT04857515
Behavior, Chemically-Induced Disorders
New York, United States
View Trial DetailsNCT01735279
Chemically-Induced Disorders, Mental Disorders
São Paulo, Brazil
View Trial Details